GZMO Message Board - Msg: 16545962

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Extra Pale who wrote (402)	10/23/2001 3:25:14 PM
From: Extra Pale	Read Replies (2) of 438

Anyone think a gzmo/genz dndn merger makes sense? dendreon has a phase III cancer vacine in the pipeline and $89m in cash on hand out of a $229m total market cap. Perhaps too much overlap between gzmo and dndn. How about cege? strong programs in vaccines and gene therapy. $220m cash plus $250m of abgx stock out of a market cap of $600. I think this would be a tough deal because cege shareholders may expect a larger premium than is warranted given the large proportion of cash and stock on the balance sheet. Any other ideas regarding companies with a late stage product and lots of cash?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next